Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
How virus affected breast screening Europe-wide
Thurs October 1st - The pressure on breast screening programmes across many European countries during the COVID-19 pandemic could lead to an increase in deaths from cancer, a conference will hear today. More
Care homes to test anti-inflammatory virus treatment
Thurs October 1st - An anti-tumour necrosis factor drug is to be tested as a community treatment for COVID-19 infection, it has been announced. More
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...

Algae hope for diagnostic nanobots

Thursday November 23rd, 2017

Remote controlled nanobots could be engineered from algae to make them biodegradeable and useful for medicine, researchers reported last night.

The nanobots were developed by Professor Li Zhang at the Chinese University of Hong Kong, together with experts at Manchester University, UK, from spirulina algae.

The algae are thought to have been a source of nourishment in central America at the time of the Aztecs. They are biodegradable and available for sale as a food substitute in health food shops.

The team investigated the compound's biodegradability to develop nanobots that degrade at a predictable rate due to an iron magnetic coating. Thanks to this feature, the nanorobots can be remotely controlled with high precision using magnetic fields to target tumours and release anti-cancer drugs.

Details appear on 22 November in Science Robotics. Professor Kostas Kostarelos from Manchester University said: "Rather than fabricate a functional microrobot from scratch using intricate laboratory techniques and processes, we set out to directly engineer smart materials in nature, which are endowed with favourable functionalities for medical applications owing to their intrinsic chemical composition.

"For instance, because these biohybrid bots have a naturally fluorescent biological interior and magnetic iron-oxide exterior, we can track and actuate a swarm of those agents inside the body quite easily using fluorescence imaging and magnetic resonance imaging."

He added that the microrobots can sense changes in environments associated with the illness onset, and adds: "We must now develop this technology further so we are able to fine tune this image-guided therapy and create a proof of concept for the engineering of multifunctional microrobotic and nanorobotic devices."

The team say they need to improve the nanobots' motion tracking, biocompatibility, biodegradation, and diagnostic and therapeutic effects.

Zhang, L. et al. Multifunctional biohybrid magnetite microrobots for imaging-guided therapy. Science Robotics 22 November 2017; doi: 10.1126/scirobotics.aaq1155

Tags: Asia | General Health | South America | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)